Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Lucid Diagnostics Q3 Adj EPS $(0.22) Beats $(0.27) Estimate, Sales $783.00K Beat $780.00K Estimate

Author: Benzinga Newsdesk | November 13, 2023 06:54pm
Lucid Diagnostics (NASDAQ:LUCD) reported quarterly losses of $(0.22) per share which beat the analyst consensus estimate of $(0.27) by 18.52 percent. This is a 21.43 percent increase over losses of $(0.28) per share from the same period last year. The company reported quarterly sales of $783.00 thousand which beat the analyst consensus estimate of $780.00 thousand by 0.38 percent. This is a 930.26 percent increase over sales of $76.00 thousand the same period last year.

Posted In: LUCD


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist